Get started
Author

Maxwell Chirehwa

Observed names: Chirehwa, Maxwell, Chirehwa, Maxwell T, Chirehwa, Maxwell Tawanda, M Chirehwa, M. Chirehwa, M. T. Chirehwa, M.T. Chirehwa, Maxwell T Chirehwa, Maxwell T. Chirehwa, Maxwell Tawanda Chirehwa
Observed institutions: University of Zimbabwe, University of Cape Town, GlaxoSmithKline (United Kingdom), Stellenbosch University, Groote Schuur Hospital, Biomedical Research and Training Institute, Hasselt University
ORCID: 0000-0002-1685-4882
Observed ORCID: 0000-0002-1685-4882
OpenAlex ID: A5072683436
CYP2B6 Genotype and Weight Gain Differences Between Dolutegravir and Efavirenz
2020 · Rulan Griesel, Gary Maartens, et al. · Clinical Infectious Diseases · 95
PDF
Model-Based Evaluation of Higher Doses of Rifampin Using a Semimechanistic Model Incorporating Autoinduction and Saturation of Hepatic Extraction
2015 · Maxwell T. Chirehwa, Roxana Rustomjee, et al. · Antimicrobial Agents and Chemotherapy · 85
Neuropsychiatric toxicity and cycloserine concentrations during treatment for multidrug-resistant tuberculosis
2021 · Richard Court, Chad M. Centner, et al. · International Journal of Infectious Diseases · 71
Use of the ‘Accountability for Reasonableness’ Approach to Improve Fairness in Accessing Dialysis in a Middle-Income Country
2016 · Mohammed Rafique Moosa, Jonathan David Maree, et al. · PLoS ONE · 64
PDF
Consequences of polyparasitism on anaemia among primary school children in Zimbabwe
2010 · N. Midzi, S. Mtapuri-Zinyowera, et al. · Acta Tropica · 59
Impact of Xpert MTB/RIF on Antiretroviral Therapy-Associated Tuberculosis and Mortality: A Pragmatic Randomized Controlled Trial
2014 · L. Mupfumi, B. Makamure, et al. · Open Forum Infectious Diseases · 58
Low Antituberculosis Drug Concentrations in HIV-Tuberculosis-Coinfected Adults with Low Body Weight: Is It Time To Update Dosing Guidelines?
2019 · Christine Sekaggya-Wiltshire, Maxwell Chirehwa, et al. · Antimicrobial Agents and Chemotherapy · 51
PDF
Effects of Genetic Variability on Rifampicin and Isoniazid Pharmacokinetics in South African Patients with Recurrent Tuberculosis
2019 · Anushka Naidoo, Maxwell Chirehwa, et al. · Pharmacogenomics · 46
Pharmacokinetics of Pyrazinamide and Optimal Dosing Regimens for Drug-Sensitive and -Resistant Tuberculosis
2017 · Maxwell T. Chirehwa, Helen McIlleron, et al. · Antimicrobial Agents and Chemotherapy · 45
PDF
Plasma Pharmacokinetics of High-Dose Oral versus Intravenous Rifampicin in Patients with Tuberculous Meningitis: a Randomized Controlled Trial
2021 · Sean Wasserman, Angharad Davis, et al. · Antimicrobial Agents and Chemotherapy · 39
Effect of rifampicin and efavirenz on moxifloxacin concentrations when co-administered in patients with drug-susceptible TB
2017 · Anushka Naidoo, Maxwell Chirehwa, et al. · Journal of Antimicrobial Chemotherapy · 37
PDF
Current research toward optimizing dosing of first-line antituberculosis treatment
2018 · Helen McIlleron, Maxwell T Chirehwa · Expert Review of Anti-infective Therapy · 36
HIV-1 Coinfection Does Not Reduce Exposure to Rifampin, Isoniazid, and Pyrazinamide in South African Tuberculosis Outpatients
2016 · Neesha Rockwood, Graeme Meintjes, et al. · Antimicrobial Agents and Chemotherapy · 34
Pharmacokinetics of First-Line Drugs in Children With Tuberculosis, Using World Health Organization–Recommended Weight Band Doses and Formulations
2021 · Chishala Chabala, Anna Turkova, et al. · Clinical Infectious Diseases · 33
PDF
Population Pharmacokinetics of Cycloserine and Pharmacokinetic/Pharmacodynamic Target Attainment in Multidrug-Resistant Tuberculosis Patients Dosed with Terizidone
2020 · Maxwell T. Chirehwa, Richard Court, et al. · Antimicrobial Agents and Chemotherapy · 32
Effect of efavirenz-based antiretroviral therapy and high-dose rifampicin on the pharmacokinetics of isoniazid and acetyl-isoniazid
2018 · Maxwell T Chirehwa, Helen McIlleron, et al. · Journal of Antimicrobial Chemotherapy · 31
Effect of Genetic Variation inUGT1AandABCB1on Moxifloxacin Pharmacokinetics in South African Patients with Tuberculosis
2017 · Anushka Naidoo, Veron Ramsuran, et al. · Pharmacogenomics · 28
Renal abnormalities among HIV-infected, antiretroviral naive children, Harare, Zimbabwe: a cross-sectional study
2013 · Vongai Dondo, Hilda A Mujuru, et al. · BMC Pediatrics · 27
PDF
Quality assurance of rifampicin-containing fixed-drug combinations in South Africa: dosing implications
2018 · R. Court, M. T. Chirehwa, et al. · The International Journal of Tuberculosis and Lung Disease · 24
Evaluation of the Effectiveness of Dose Individualization to Achieve Therapeutic Vancomycin Concentrations
2018 · Ahmed A. Abulfathi, Maxwell Chirehwa, et al. · The Journal of Clinical Pharmacology · 21
Early antituberculosis drug exposure in hospitalized patients with human immunodeficiency virus‐associated tuberculosis
2020 · Charlotte Schutz, Maxwell Chirehwa, et al. · British Journal of Clinical Pharmacology · 18
PDF
Adverse Drug Reactions in Paediatric In-Patients in a South African Tertiary Hospital
2018 · Memela Makiwane, Eric Decloedt, et al. · Journal of Tropical Pediatrics · 18
Changes in causes of pregnancy-related and maternal mortality in Zimbabwe 2007-08 to 2018-19: findings from two reproductive age mortality surveys
2022 · Reuben Musarandega, Solwayo Ngwenya, et al. · BMC Public Health · 17
PDF
Pharmacokinetics and other risk factors for kanamycin-induced hearing loss in patients with multi-drug resistant tuberculosis
2019 · Nazanin Ghafari, Richard Court, et al. · International Journal of Audiology · 15
Effect of tablet crushing on drug exposure in the treatment of multidrug-resistant tuberculosis
2019 · R. Court, M. T. Chirehwa, et al. · The International Journal of Tuberculosis and Lung Disease · 14
Works count: 60
Citation count: 1,117
H-index: 20
I10-index: 28
Year
Topic
Type